College of Veterinary Medicine, Northwest A&F University, Key Laboratory of Animal Biotechnology of the Ministry of Agriculture, Yangling, Shaanxi, China.
PLoS One. 2013 Jun 14;8(6):e65379. doi: 10.1371/journal.pone.0065379. Print 2013.
The present study was conducted to determine whether recombinant human β-defensin-3 (rHBD3) in the milk of transgenic goats has an anti-bacterial activity against Escherichia coli (E. coli), Staphylococcus aureus (S. aureus) and Streptococcus agalactiae (S. agalactiae) that could cause mastitis. A HBD3 mammary-specific expression vector was transfected by electroporation into goat fetal fibroblasts which were used to produce fourteen healthy transgenic goats by somatic cell nuclear transfer. The expression level of rHBD3 in the milk of the six transgenic goats ranged from 98 to 121 µg/ml at 15 days of lactation, and was maintained at 90-111 µg/ml during the following 2 months. Milk samples from transgenic goats showed an obvious inhibitory activity against E. coli, S. aureus and S. agalactiae in vitro. The minimal inhibitory concentrations of rHBD3 in milk against E. coli, S. aureus and S. agalactiae were 9.5-10.5, 21.8-23.0 and 17.3-18.5 µg/mL, respectively, which was similar to those of the HBD3 standard (P>0.05). The in vivo anti-bacterial activities of rHBD3 in milk were examined by intramammary infusion of viable bacterial inoculums. We observed that 9/10 and 8/10 glands of non-transgenic goats infused with S. aureus and E. coli became infected. The mean numbers of viable bacteria went up to 2.9×10(3) and 95.4×10(3) CFU/ml at 48 h after infusion, respectively; the mean somatic cell counts (SCC) in infected glands reached up to 260.4×10(5) and 622.2×10(5) cells/ml, which were significantly higher than the SCC in uninfected goat glands. In contrast, no bacteria was presented in glands of transgenic goats and PBS-infused controls, and the SSC did not significantly change throughout the period. Moreover, the compositions and protein profiles of milk from transgenic and non-transgenic goats were identical. The present study demonstrated that HBD3 were an effective anti-bacterial protein to enhance the mastitis resistance of dairy animals.
本研究旨在确定转人β-防御素-3(rHBD3)是否存在于转基因羊奶中,以拮抗引起乳腺炎的大肠杆菌(E. coli)、金黄色葡萄球菌(S. aureus)和无乳链球菌(S. agalactiae)。我们用电穿孔法将 HBD3 乳腺特异性表达载体转染到山羊胎儿成纤维细胞中,然后通过体细胞核移植生产了 14 只健康的转基因山羊。在泌乳第 15 天,6 只转基因山羊羊奶中 rHBD3 的表达水平为 98-121μg/ml,之后的 2 个月内维持在 90-111μg/ml。羊奶样品对大肠杆菌、金黄色葡萄球菌和无乳链球菌均具有明显的体外抑制活性。羊奶中 rHBD3 对大肠杆菌、金黄色葡萄球菌和无乳链球菌的最小抑菌浓度分别为 9.5-10.5、21.8-23.0 和 17.3-18.5μg/ml,与 HBD3 标准品相似(P>0.05)。通过向乳腺内注入活菌,检测了羊奶中 rHBD3 的体内抗菌活性。我们发现,金黄色葡萄球菌和大肠杆菌感染的非转基因山羊中,有 9/10 和 8/10 个乳区受到感染。感染后 48 h,活细菌数分别上升至 2.9×10(3)和 95.4×10(3)CFU/ml;感染乳区的总体细胞计数(SCC)分别高达 260.4×10(5)和 622.2×10(5)细胞/ml,显著高于未感染乳区的 SCC。相比之下,转基因和 PBS 对照组的乳区中均未检出细菌,SCC 在整个实验过程中没有明显变化。此外,转基因和非转基因山羊的羊奶成分和蛋白图谱相同。本研究表明,HBD3 是一种有效的抗菌蛋白,可增强奶牛的抗乳腺炎能力。